TSHA- Taysha Gene Therapies, Inc.

TSHA sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Nolan Sean P.	2.91M	$13.41M	-
CFO	Alam Kamran	1.44M	$6.52M	-
Dir	Stalfort John A III	1.18M	-	-
Pres	Nagendran Sukumar	936.4K	$5.84M	-
Dir	Donenberg Phillip B.	241.3K	-	-

Buys and sells only

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 21, 2025	Alam Kamran83	Chief Financial Officer	Sell	54,491	$2.85	$155,299.35	-4.4%	+39.7%	-
May 30, 2025	Manning Paul B54	10% Owner	Buy	750,000	$2.75	$2,062,500.00	+35.9%	+4.4%	+116.6%
Jun 27, 2024	Manning Paul B54	10% Owner	Buy	1,333,333	$2.25	$2,999,999.25	New	-7.2%	+9.9%
Nov 17, 2023	Manning Paul B54	10% Owner	Buy	100,000	$1.63	$163,000.00	+0.6%	-6.5%	+21.2%
Aug 24, 2023	Alam Kamran83	Chief Financial Officer	Sell	33,000	$2.33	$76,890.00	-11.3%	-21.4%	-6.0%
Aug 16, 2023	Manning Paul B54	10% Owner	Buy	16,466,667	$0.90	$14,820,000.30	New	-31.1%	+18.7%
Aug 16, 2023	Stalfort John A III	Director	Buy	777,778	$0.90	$700,000.20	+351.0%	-31.1%	+18.7%
Aug 16, 2023	Nolan Sean P.	Chief Executive Officer	Buy	444,444	$0.90	$399,999.60	+40.7%	-31.1%	+18.7%
Aug 16, 2023	Donenberg Phillip B.	Director	Buy	111,111	$0.90	$99,999.90	+3,704%	-31.1%	+18.7%
Jul 13, 2023	Session R.A. II	10% Owner	Sell	85,872	$0.71	$60,770.73	-1.0%	+252.9%	+238.6%